Peter Zipfel GermanyLeibniz Institute for Natural Product Research and Infection Biology

Peter Zipfel
Peter F. Zipfel, is University-Professor at Friedrich Schiller University, Jena and Department Head at the Leibniz Institute for Natural Product Research and Infection Biology - e in Jena Germany. His research focuses on complement in health and disease, the role of the complement system in HUS and C3 Glomerulopathy, and as target for human pathogenic microbes. Dr. Zipfel has a deep interest in complement factor H, and in Factor H related proteins. Dr. Zipfel received his PhD from the University of Bremen. He was a postdoctoral fellow in the Laboratory for Immunoregulation, National Institutes of Health in Bethesda, Maryland USA headed by Dr. Anthony Fauci. Dr. Zipfel was then Group -eader at Bernhard Nocht Institute for Tropical Medicine Hamburg and Professor at the University of Hamburg. He has organized in 2013 the 14th European Meeting on Complement in Human Diseases and the 28th International Complement workshop in the year 2021.
Institution

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10:30 a.m.
SK06
Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce
  • Updates on IgAN Management
    HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES
  • Membranous GN Classification and Management
    PierreRonco Speaker FranceHôpital Tenon
  • MPGN Updates
    SanjeevSethi Speaker United StatesMayo Clinic
  • Managing Vasculitis
    RobertaFenoglio Speaker roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco
  • Q and A
Hall A
12:30 p.m.
1:30 p.m.
SK1003
AnujaJava Chairperson United StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS
LizLightstone Chairperson United KingdomImperial College London
  • Complement in Kidney Disease: Overview of the Complement Cascade in Kidney Injury
    Peter Zipfel Speaker Peter.Zipfel@hki-jena.deGermanyLeibniz Institute for Natural Product Research and Infection Biology
  • C3 Glomerulopathy: New Developments and Therapeutic Targets
    CarlaNester Speaker carla-nester@uiowa.eduUnited StatesUniversity of Iowa
  • Challenges in Diagnosing C3G
    SallyJohnson Speaker sallyajohnson73@gmail.comUnited KingdomNational Renal Complement Therapeutics Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, United Kingdom
  • Q and A
Hall C1